| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |